InvestorsHub Logo

Mistafixit

03/27/17 9:22 PM

#75986 RE: Joemarly #75974

Yes we are waiting for the study results that were said to be completed in the last 8k. This will take time to complete but I'm assuming we will get a pr soon. They are starting new testing on other skin conditions which haven't been named just speculation. There will be at least three ground breaking PR's this year. Efficacy results, singular tablet updates, revenue from cream product, and more. Both the cream and singular tablet can treat multiple disorders and OWC is setting out to prove that. It's too risky not to own shares here IMHO. GLTY and all

skitahoe

03/27/17 9:33 PM

#75989 RE: Joemarly #75974

No Joe, the comment on the effectiveness of the psoriasis cream was the initial indication of what was seen in an Israeli trial done for the efficacy of the drug. While a review of this trial in depth hasn't been made yet, it will be and hopefully will be presented for peer review, then shared with investors.

Their is another trial that has FDA concurrence, it's only for safety and is being run with healthy patients to validate the fact that their are no safety concerns. I believe it should be concluded in the second quarter.

It's my belief that the FDA insisted on this trial before they'd permit the cream to be sold in the U.S. as a cosmetic. Clearly the efficacy trial should also have demonstrated safety, but the FDA IMHO wanted to show that they had a hand in this, so they demanded the additional safety trials.

I'm frankly taking others words on the fact that Israeli efficacy trials are accepted in much of the world. I'm unclear whether in Israel and elsewhere the cream will be sold as a cosmetic, or a drug. Time will tell.

Gary